Journals / Anadolu Psikiyatri Dergisi / 2010 / Cilt: 11 - Sayı: 4

Testosterone and 17-OH progesteron levels in women with depression and the effects of antidepressant treatmen

Depresyonlu kadın hastalarda testosteron ve 17-OH progesteron düzeyleri ve antidepresan tedavinin etkisi

Pages
285–292
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Elevated levels of testosterone in depressed women might be a result of over activation of the adrenal glands, which are the main source of this hormone in women.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Women suffer from depression more often than males, indicating that sex hormones might be involved in the etiology of this disease.
📊
Key Findings & Data:The aim of this study was to investigate whether testosterone and 17-OH pro-gesterone are related to the pathophysiology of depression in depressed women.
💡
Conclusion & Impact:Elevated levels of testosterone in depressed women might be a result of over activation of the adrenal glands, which are the main source of this hormone in women.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Women suffer from depression more often than males, indicating that sex hormones might be involved in the etiology of this disease. The aim of this study was to investigate whether testosterone and 17-OH pro-gesterone are related to the pathophysiology of depression in depressed women. We also investigated if any alteration takes place in these hormonal variables with antidepressant treatment. Methods: Forty female inpa-tients suffering from a depressive episode and 20 healthy female controls were recruited in the study. In the patient and control groups, serum total testosterone, 17-OH progesterone and SHBG levels were assayed. Pharmacotherapy was given to the patient group for 6-10 weeks (venlafaxine n=19, fluoxetine n=12, imipramine n=9). Hormonal measurements were repeated after the treatment in the patient group who responded to antidepressant treatment. Results: Serum testosterone levels were higher in the depressive women than in the healthy women. The testosterone levels were normalized by antidepressant treatment. 17-OH progesterone and SHBG levels did not differ between patients and controls. Conclusions: The result of normalized testosterone levels with pharmacotherapy suggests that testosterone may have a relationship with depression. Elevated levels of testosterone in depressed women might be a result of over activation of the adrenal glands, which are the main source of this hormone in women.

Özet

Amaç: Kadınların depresyona erkeklerden daha çok yakalanması, cinsiyet hormonlarının bu hastalığın etiyoloji-sinde bir etkisinin olabileceğini düşündürmektedir. Bu çalışmanın amacı depresyonlu kadınlarda testosteron ve 17-OH progesteronun depresyonun patofizyolojisiyle ilişkili olup olmadığını incelemektir. Ayrıca antidepresan tedaviyle bu hormonal parametrelerde herhangi bir değişim olup olmadığını da araştırdık. Yöntem: Depresif nöbet içinde bulunan 40 kadın hasta ve 20 sağlıklı kadın kontrol çalışmaya alındı. Hasta ve kontrol grubunda serum total testosteron, 17-OH progesteron ve SHBG düzeyleri ölçüldü. Hasta grubuna 6-10 hafta boyunca farmakoterapi uygulandı (venlafaksin s=19, fluoksetin s=12, imipramin s=9). Antidepresan tedaviye yanıt veren hasta grubunda hormonal ölçümler tedaviden sonra tekrarlandı. Bulgular: Serum testosteron düzeyi depresif kadınlarda sağlıklı kadınlarden yüksekti. Yüksek testosteron düzeyi antidepresan tedaviyle normale döndü. 17-OH progesteron ve SHBG düzeyleri hasta ve kontroller arasında farklı değildi. Sonuçlar: Farmakoterapiyle testosteronun normal düzeye inmesi, testosteronun depresyonla bir ilişkisinin olabileceğini düşündürmektedir. Depresif kadınlarda testosteronun yükselmiş düzeyi, kadınlarda bu hormonun ana kaynağı olan adrenal bezin aşırı aktivitesinin bir sonucu olabilir.

🔖

Cite This Article

KARTALCI, Ş., ÖZSOY, S., ÜNAL, S., EŞEL, E. (2010). Testosterone and 17-OH progesteron levels in women with depression and the effects of antidepressant treatmen. Anadolu Psikiyatri Dergisi, Cilt: 11 - Sayı: 4, 285–292. https://ajindex.com/articles/355898

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Steiner M, Dunn E, Born L. Hormones and mood: from menarche to menopause and beyond. J Affect Disord 2003; 74:67-83
  2. Rohr UD. The impact of testosterone imbalance on depression and women's health. Maturitas 2002; 41(Suppl.1):25-46
  3. Zarrouf FA, Artz S, Griffith J, Sirbu C, Kommor M. Testosterone and depression: systematic review and meta-analysis. J Psychiatr Pract 2009; 15:289-305
  4. Davies RH, Harris B, Thomas DR, Cook N, Read G, Riad-Fahmy D. Salivary testosterone levels and major depressive illness in men. Br J Psychiatry 1992; 161:629-632
  5. Levitt AJ, Joffe RT. Total and free testosterone in depressed men. Acta Psychiatr Scand 1988; 77:346-348
  6. Shores MM, Moceri VM, Sloan KL, Matsumoto AM, Kivlahan DR. Low testosterone levels predict incident depressive illness in older men: effects of age and medical morbidity. J Clin Psychiatry 2005; 66:7-14
  7. Ozsoy S, Esel E, Hacimusalar Y, Candan Z, Kula M, Turan T. Acute and chronic effects of electroconvulsive therapy on neuroactive steroids in patients with major depressive disorder. Turk Psikiyatri Derg 2008; 19:341-348
  8. McIntyre RS, Mancini D, Eisfeld BS, Soczynska JK, Grupp L, Konarski JZ, et al. Calculated bioavailable testosterone levels and depression in middle-aged men. Psychoneuroendocrinology 2006; 31:1029-1035
  9. Delhez M, Hansenne M, Legros JJ. Andropause and psychopathology: Minor symptoms rather than pathological ones. Psychoneuroendocrinology 2003; 28:863-274
  10. Vermeulen A. Diagnosis of partial androgen deficiency in the aging male. Ann Endocrinol (Paris) 2003; 64:109-114
  11. Seidman SN. Testosterone deficiency and mood in aging men: Pathogenic and therapeutic interactions. World J Biol Psychiatry 2003; 4:14-20
  12. Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, et al. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 2004; 89:2085-2098
  13. Vogel W, Klaiber EL, Broverman DM. A comparison of the antidepressant effects of a synthetic androgen (mesterolone) and amitriptyline in depressed men. J Clin Psychiatry 1985; 46:6-8
  14. Weber B, Lewicka S, Deuschle M, Colla M, Heuser I. Testosterone, androstenedione and dihydrotestosterone concentrations are elevated in female patients with major depression. Psychoneuroendocrinology 2000; 25:765-771
  15. Morsink LF, Vogelzangs N, Nicklas BJ, Beekman AT, Satterfield S, Rubin